MedTrace Logo

Arthroscopic Treatment Combine With TXA for Elbow Stiffness

NCT05138913 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-12-01

No results posted yet for this study

Summary

This study is a prospective randomized controlled study of different arthroscopic treatments for elbow stiffness combined with tranexamic acid(TXA) injection. The patients with stiffness were randomly divided into groups before the operation. After the arthroscopic operation was completed, they were divided into a local TXA injection group and a control group (normal saline) to perform additional operations for reduction of hemorrhage. In different time periods, the quantitative and qualitative indicators including pain, functional score, range of motion, level of Hemoglobin, the circumference of the limb 10cm above and below the elbow, amount of hemorrhage, etc. were compared between groups at the same time period to evaluate the difference in the effect of arthroscopic treatment combined with TXA on the treatment of reduction of hemorrhage. Determine the effectiveness of TXA.

Conditions

  • Tranexamic Acid
  • Elbow Stiffness

Interventions

DRUG

TXA

After the arthroscopic operation was completed, a local TXA injection was performed

DRUG

Saline

After the arthroscopic operation was completed, a local saline injection was performed

Sponsors & Collaborators

  • Beijing Jishuitan Hospital

    lead OTHER

Principal Investigators

  • Yi Lu · Sports Medicine Service, Beijing Jishuitan hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-12-30
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05138913 on ClinicalTrials.gov